There is less of a change to the AR when Tfap2a is overexpressed in a stable NPC clonal line, demonstrating that differences in TFAP2a binding have the strongest effect during the initiation and establishment stage of aRME. The gene discussed is TFAP2A; the disease is nasopharyngeal carcinoma.